Kazım Şahin
Research Subjects
Research Interests
Kazım Şahin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Enes Şahin
Department of General Surgery, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye
4 shared publications - Nihat Zafer Utkan
Department of General Surgery, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye
4 shared publications - Sertaç Ata Güler
Department of General Surgery, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye
4 shared publications - Haşim Köken
KOCAELİ ÜNİVERSİTESİ ARAŞTIRMA VE UYGULAMA HASTANESİ
2 shared publications - Mehmet Eşref Ulutaş
Department of Surgery, Gaziantep City Hospital, University of Health Sciences, Gaziantep, Türkiye
2 shared publications - Nuh Zafer Cantürk
Kocaeli University
2 shared publications
Latest Publications
- 1 March 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (3) , 182-186
The effect of COVID-19 pandemic period on the treatment process of colorectal cancer patients
Aim Guidelines published during the COVID-19 pandemic generally recommended postponing cancer surgeries except in emergencies. However, the impact of this approach on the progression of cancer cases has not yet been clearly determined. In this study, we aimed to compare the clinical data and outcomes of colorectal cancer surgeries conducted before, during, and after the pandemic. Methods This retrospective cohort study included patients who underwent surgery for colorectal cancer during three distinct periods: prepandemic (February 1, 2019 - December 31, 2019), pandemic (August 1, 2020 - June 30, 2021), and post-pandemic (April 1, 2021 - August 1, 2021). Demographic data, clinical and laboratory findings, operational details, and post-discharge follow-up information were collected by reviewing patient files. The three groups were compared based on these data. Results A total of 79 patients were included in the study: 29 (8 females and 21 males) were operated on before the pandemic, 18 (5 females and 13 males) during the pandemic, and 30 (9 females and 21 males) after the pandemic. One patient (3.4%) in the pre-pandemic period, 11 patients (37.9%) during the pandemic period, and five patients (16.7%) after the pandemic were operated on for emergency reasons (p<0.001). When examining TNM stages, the most common stage 2 tumors were observed before the pandemic (37.93%), while stage 2 and stage 4 tumors (33.3% each) were most prevalent during the pandemic, and stage 4 tumors (36.7%) were the most common in the post-pandemic period (p=0.67). Ostomy rates were 3.4% in the pre-pandemic period, 33.3% in the pandemic period, and 13.4% in the post-pandemic period (p=0.017) Conclusion The rise in cases needing emergency surgery and the surge in ostomy rates during the pandemic highlights the negative effects of this process on surgical treatment for colorectal cancer.
- 1 March 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (3) , 182-186
The effect of COVID-19 pandemic period on the treatment process of colorectal cancer patients
Aim Guidelines published during the COVID-19 pandemic generally recommended postponing cancer surgeries except in emergencies. However, the impact of this approach on the progression of cancer cases has not yet been clearly determined. In this study, we aimed to compare the clinical data and outcomes of colorectal cancer surgeries conducted before, during, and after the pandemic. Methods This retrospective cohort study included patients who underwent surgery for colorectal cancer during three distinct periods: prepandemic (February 1, 2019 - December 31, 2019), pandemic (August 1, 2020 - June 30, 2021), and post-pandemic (April 1, 2021 - August 1, 2021). Demographic data, clinical and laboratory findings, operational details, and post-discharge follow-up information were collected by reviewing patient files. The three groups were compared based on these data. Results A total of 79 patients were included in the study: 29 (8 females and 21 males) were operated on before the pandemic, 18 (5 females and 13 males) during the pandemic, and 30 (9 females and 21 males) after the pandemic. One patient (3.4%) in the pre-pandemic period, 11 patients (37.9%) during the pandemic period, and five patients (16.7%) after the pandemic were operated on for emergency reasons (p<0.001). When examining TNM stages, the most common stage 2 tumors were observed before the pandemic (37.93%), while stage 2 and stage 4 tumors (33.3% each) were most prevalent during the pandemic, and stage 4 tumors (36.7%) were the most common in the post-pandemic period (p=0.67). Ostomy rates were 3.4% in the pre-pandemic period, 33.3% in the pandemic period, and 13.4% in the post-pandemic period (p=0.017) Conclusion The rise in cases needing emergency surgery and the surge in ostomy rates during the pandemic highlights the negative effects of this process on surgical treatment for colorectal cancer.
- Open Access
- 30 December 2024
- Published by Bulent Evcevit University in Medical Journal of Western Black Sea
- Vol. 8 (3) , 283-290
Five Year Follow Up Results of Surgically Treated Rectal Cancer Case, Who Had Neoadjuvan Chemotheraph
Aim: We wanted to investigate whether the watch and wait method without surgery or surgery is superior in patients with rectal cancer receiving neoadjuvant treatment. Material and Methods: The clinical data of case above the age of 18 who were diagnosed with rectal tumors between 2018 and 2023 were retrospectively analyzed. Results: After neoadjuvant treatment, the mass disappeared completely in some case. All case were operated after neoadjuvant treatment. Adenocarcinoma was seen in 140 (80%) case operated after neoadjuvant treatment, normal colon wall was seen in 10 (5.5%) case and chronic inflammation was seen in 20 (11%) case. Conclusion: The importance of neoadjuvant treatment according to the stage of the disease in case with rectal cancer is being better understood day by day. Early surgery is recommended as the first-line treatment for early-stage rectal cancer due to its favorable outcomes. However, it has been widely accepted that in locally advanced or advanced rectal cancers with lymph node metastasis, neoadjuvant treatment before surgery is much more beneficial in terms of disease-free survival and survey after surgery
- 30 December 2024
- Published by Bulent Evcevit University in Medical Journal of Western Black Sea
- Vol. 8 (3) , 283-290
Open AccessFive Year Follow Up Results of Surgically Treated Rectal Cancer Case, Who Had Neoadjuvan Chemotheraph
Aim: We wanted to investigate whether the watch and wait method without surgery or surgery is superior in patients with rectal cancer receiving neoadjuvant treatment. Material and Methods: The clinical data of case above the age of 18 who were diagnosed with rectal tumors between 2018 and 2023 were retrospectively analyzed. Results: After neoadjuvant treatment, the mass disappeared completely in some case. All case were operated after neoadjuvant treatment. Adenocarcinoma was seen in 140 (80%) case operated after neoadjuvant treatment, normal colon wall was seen in 10 (5.5%) case and chronic inflammation was seen in 20 (11%) case. Conclusion: The importance of neoadjuvant treatment according to the stage of the disease in case with rectal cancer is being better understood day by day. Early surgery is recommended as the first-line treatment for early-stage rectal cancer due to its favorable outcomes. However, it has been widely accepted that in locally advanced or advanced rectal cancers with lymph node metastasis, neoadjuvant treatment before surgery is much more beneficial in terms of disease-free survival and survey after surgery
- 1 September 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (9) , 631-634
The effect of COVID-19 pandemic period on the diagnosis and treatment process of breast cancer patients
Aim The aim of this study was to determine the effect of the pandemic on breast cancer surgery. Methods The study was conducted retrospectively. Breast cancer patients who were operated in 2020 were considered as the pandemic period group, and those operated in the previous year (2019) and the following year (2021) were considered the non-pandemic group. The study was completed by comparing the demographic, pathological and clinical data of the patients. Results A total of 78 patients, 31 in 2019, 16 in 2020, and 31 in 2021, were included in our study (P = .07). Tumour sizes were 2.4 ( ± 1.2) cm in 2019, 2.4 ( ± 1.3) cm in 2020, and 2 ( ± 0.6) cm in 2021 (P = .23). The tumour was most commonly located on the left side in all years. (P = .84) The most common tumour type in all years was invasive ductal carcinoma (P = .62). Breast conserving surgery (BCS) and sentinel lymph node biopsy (SLNB) were performed most frequently in all years. (P = .07) In 2019, 3.2% (n = 1), in 2020, 18.8% (n = 3), and in 2021, 19.4% (n = 6) of the patients received neoadjuvant treatment (P = .15). When the preoperative stages were analysed, patients were most commonly stage 1 breast cancer in all years (P = .71). Conclusion Our study does not support the information stated by previous studies that the pandemic decreased the rate of breast cancer diagnosis and increased the rate of advanced breast cancer cases. However, when the long-term effects of the pandemic are analysed, it will be much clearer whether these effects are present.
- 1 September 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (9) , 631-634
The effect of COVID-19 pandemic period on the diagnosis and treatment process of breast cancer patients
Aim The aim of this study was to determine the effect of the pandemic on breast cancer surgery. Methods The study was conducted retrospectively. Breast cancer patients who were operated in 2020 were considered as the pandemic period group, and those operated in the previous year (2019) and the following year (2021) were considered the non-pandemic group. The study was completed by comparing the demographic, pathological and clinical data of the patients. Results A total of 78 patients, 31 in 2019, 16 in 2020, and 31 in 2021, were included in our study (P = .07). Tumour sizes were 2.4 ( ± 1.2) cm in 2019, 2.4 ( ± 1.3) cm in 2020, and 2 ( ± 0.6) cm in 2021 (P = .23). The tumour was most commonly located on the left side in all years. (P = .84) The most common tumour type in all years was invasive ductal carcinoma (P = .62). Breast conserving surgery (BCS) and sentinel lymph node biopsy (SLNB) were performed most frequently in all years. (P = .07) In 2019, 3.2% (n = 1), in 2020, 18.8% (n = 3), and in 2021, 19.4% (n = 6) of the patients received neoadjuvant treatment (P = .15). When the preoperative stages were analysed, patients were most commonly stage 1 breast cancer in all years (P = .71). Conclusion Our study does not support the information stated by previous studies that the pandemic decreased the rate of breast cancer diagnosis and increased the rate of advanced breast cancer cases. However, when the long-term effects of the pandemic are analysed, it will be much clearer whether these effects are present.
- 1 January 2024
- Published by Bayrakol Medical Publishing in Eurasian Clinical and Analytical Medicine
- Vol. 12 (03) , 36-40
An investigation of medical school students’ level of knowledge on breast cancer and their attitudes toward breast self-examination
- 1 January 2024
- Published by Bayrakol Medical Publishing in Eurasian Clinical and Analytical Medicine
- Vol. 12 (03) , 36-40
An investigation of medical school students’ level of knowledge on breast cancer and their attitudes toward breast self-examination